Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Insmed USD -230414000 16.98M 2024-12
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Kyowa Hakko Kirin JPY 7.43B 19.5B 2025-03
MacroGenics USD -16587000 70.78M 2024-12
Moderna USD -1050000000 196M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Ultragenyx Pharmaceutical Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.